The presence of tumor cells and the extent of the viable tumor burden are believed to be closely linked to the chemo-response to NAT.12,13 Depending on the tumor response to NAT, patient prognosis and the effect of the adjuvant treatment can be predicted. This evidence concerns the gene BRD2 and neoplasm.